Title |
Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial
|
---|---|
Published in |
Cardiovascular Diabetology, November 2011
|
DOI | 10.1186/1475-2840-10-102 |
Pubmed ID | |
Authors |
Russell Scott, Mark Donoghoe, Gerald F Watts, Richard O'Brien, Christopher Pardy, Marja-Riitta Taskinen, Timothy ME Davis, Peter G Colman, Patrick Manning, Gregory Fulcher, Anthony C Keech, The FIELD Study Investigators |
Abstract |
Patients with the metabolic syndrome are more likely to develop type 2 diabetes and may have an increased risk of cardiovascular disease (CVD) events.We aimed to establish whether CVD event rates were influenced by the metabolic syndrome as defined by the World Health Organisation (WHO), the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) and the International Diabetes Federation (IDF) and to determine which component(s) of the metabolic syndrome (MS) conferred the highest cardiovascular risk in in 4900 patients with type 2 diabetes allocated to placebo in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Denmark | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 116 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 19 | 16% |
Student > Bachelor | 16 | 14% |
Researcher | 14 | 12% |
Student > Ph. D. Student | 12 | 10% |
Student > Postgraduate | 10 | 8% |
Other | 26 | 22% |
Unknown | 21 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 47 | 40% |
Nursing and Health Professions | 17 | 14% |
Biochemistry, Genetics and Molecular Biology | 5 | 4% |
Agricultural and Biological Sciences | 5 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
Other | 16 | 14% |
Unknown | 23 | 19% |